CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-28 | Adelman Michael SVP, Commercial Operations | Grant or award · Stock Option (right to buy) | +67,400 | 67,400 | ||
| 2018-12-06 | Maddux Randy Joe SVP Operations | Purchase | +5,000 | $2.37 | $12K | 30,000 |
| 2018-12-04 | White Marvin L President and CEO | Purchase | +10,000 | $2.38 | $24K | 203,603 |
| 2018-08-09 | Mitchell Shawnte SVP, GC and Corporate Affairs | Option exercise | +1,630 | 76,135 | ||
| 2018-08-09 | Mitchell Shawnte SVP, GC and Corporate Affairs | Shares withheld for taxes | −383 | $4.50 | $2K | 75,752 |
| 2018-08-09 | Mitchell Shawnte SVP, GC and Corporate Affairs | Option exercise · Restricted Stock Units | −1,630 | 6,787 | ||
| 2018-06-01 | Niederhuber John Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-06-01 | Kunz Barbara Lopez Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-06-01 | Harsanyi Zsolt Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-06-01 | Grant Grady III Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-06-01 | El-Hibri Fuad Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-06-01 | Abdun-Nabi Daniel Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-05-21 | White Marvin L President and CEO | Option exercise | +35,644 | 201,976 | ||
| 2018-05-21 | White Marvin L President and CEO | Shares withheld for taxes | −8,373 | $5.61 | $47K | 193,603 |
| 2018-05-21 | White Marvin L President and CEO | Option exercise · Restricted Unit Stock | −35,644 | 0 | ||
| 2018-03-19 | White Marvin L President and CEO | Purchase | +100,000 | $2.93 | $293K | 166,332 |
| 2018-03-19 | White Marvin L President and CEO | Sale | +100,000 | $2.93 | $293K | 166,332 |
| 2018-03-10 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise | +6,747 | 71,459 | ||
| 2018-03-10 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Shares withheld for taxes | −1,583 | $3.13 | $5K | 69,876 |
| 2018-03-10 | Lamothe Jeffrey G. SVP, CFO and Treasurer | Option exercise · Restricted Stock Unit | −6,747 | 7,318 |
Page 21 of 23 · 445 trades